Catalyst Event
DICK'S Sporting Goods Inc (DKS) · Other
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
4/16/2026, 12:00:00 AM
Scheduled for April 16, 2026, BTIG initiated coverage with a 'Buy' rating and a $300 price target, citing potential upside from the Foot Locker acquisition; low importance as analyst initiations typically have limited price impact, estimated.
Korean Translation
2026년 4월 16일 BTIG가 풋락커 인수로 인한 상승 여력을 근거로 '매수' 등급과 목표 주가 300달러로 커버리지를 개시함. 애널리스트의 커버리지 개시는 통상 주가에 미치는 영향이 제한적이므로 중요도를 'Low'로 평가하며, 이는 2026년 4월 16일로 전망됨.
Related Recent Events
Novo Nordisk A/S (NVO) · Earnings Release
Novo Nordisk is scheduled to release its Q1 2026 earnings report before the market opens on May 6, 2026, with high importance estimated due to potential 10% price impact, expected.
5/6/2026, 12:00:00 AM
Life Time Group Holdings Inc (LTH) · Earnings Release
Life Time Group Holdings is scheduled to report its Q1 2026 financial results. A moderate market reaction is estimated for this standard earnings release scheduled.
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Eli Lilly is scheduled to announce its first-quarter 2026 financial results on April 30, 2026, followed by a conference call. High impact is estimated due to significant market focus on GLP-1 sales growth scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck & Co. is scheduled to release its Q1 2026 earnings on April 30, 2026; impact is estimated as neutral pending the actual report, scheduled.
4/30/2026, 12:00:00 AM
Amgen Inc (AMGN) · Earnings Release
Amgen is expected to report its Q1 2026 financial results after the market closes on April 30, 2026, scheduled. Analysts estimate a Low impact (~1-2%) as a standard scheduled reporting event, scheduled.
4/30/2026, 12:00:00 AM
Astrazeneca PLC (AZN) · Earnings Release
AstraZeneca's Q1 2026 results announcement is scheduled for April 29, 2026 scheduled
4/29/2026, 12:00:00 AM